Financial results - ANNEMEDICA PHARM SRL

Financial Summary - Annemedica Pharm Srl
Unique identification code: 30730716
Registration number: J07/380/2012
Nace: 7500
Sales - Ron
201.272
Net Profit - Ron
31.127
Employee
3
The most important financial indicators for the company Annemedica Pharm Srl - Unique Identification Number 30730716: sales in 2023 was 201.272 euro, registering a net profit of 31.127 euro and having an average number of 3 employees. Firma isi desfasoara activitatea in domeniul Activitati veterinare having the NACE code 7500.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Annemedica Pharm Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 56.451 60.901 98.338 125.847 119.587 123.145 167.435 140.087 154.715 201.272
Total Income - EUR 56.536 61.017 98.810 126.674 120.104 123.844 169.114 140.932 155.999 202.942
Total Expenses - EUR 46.664 44.577 80.581 92.417 91.292 100.614 122.346 108.689 131.178 169.988
Gross Profit/Loss - EUR 9.872 16.441 18.229 34.257 28.813 23.230 46.768 32.243 24.820 32.954
Net Profit/Loss - EUR 8.176 14.610 17.241 32.999 27.617 21.986 45.341 31.182 23.260 31.127
Employees 0 2 3 3 0 3 4 3 2 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 30.5%, from 154.715 euro in the year 2022, to 201.272 euro in 2023. The Net Profit increased by 7.937 euro, from 23.260 euro in 2022, to 31.127 in the last year.

Check the financial reports for the company - Annemedica Pharm Srl

Rating financiar

Financial Rating -
Annemedica Pharm Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Annemedica Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Annemedica Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Annemedica Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Annemedica Pharm Srl - CUI 30730716

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 10.086 18.131 17.433 16.031 14.915 13.819 15.865 42.445 35.588 29.332
Current Assets 12.987 19.683 32.016 41.731 34.712 36.206 46.809 58.914 54.761 70.043
Inventories 7.041 12.741 21.175 19.010 21.295 28.956 34.876 45.766 50.283 56.321
Receivables 1.229 2.039 1.436 7.613 2.560 1.508 3.694 1.124 68 2.900
Cash 4.717 4.903 9.405 15.108 10.857 5.742 8.239 12.024 4.410 10.821
Shareholders Funds 9.098 23.784 18.181 34.017 28.625 22.978 57.423 87.331 75.750 83.459
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 13.974 14.029 31.268 23.746 21.002 27.047 5.251 14.028 14.599 15.915
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "7500 - 7500"
CAEN Financial Year 7500
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 70.043 euro in 2023 which includes Inventories of 56.321 euro, Receivables of 2.900 euro and cash availability of 10.821 euro.
The company's Equity was valued at 83.459 euro, while total Liabilities amounted to 15.915 euro. Equity increased by 7.939 euro, from 75.750 euro in 2022, to 83.459 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Annemedica Pharm Srl

Comments - Annemedica Pharm Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.